Rockwell Medical, Inc. (NASDAQ:RMTI – Free Report) – Investment analysts at HC Wainwright lifted their Q1 2024 EPS estimates for shares of Rockwell Medical in a report released on Monday, March 25th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.05) for the quarter, up from their previous estimate of ($0.07). HC Wainwright has a “Buy” rating and a $9.00 price objective on the stock. The consensus estimate for Rockwell Medical’s current full-year earnings is ($0.11) per share. HC Wainwright also issued estimates for Rockwell Medical’s Q2 2024 earnings at ($0.03) EPS and Q3 2024 earnings at ($0.02) EPS.
Rockwell Medical Price Performance
Rockwell Medical stock opened at $1.66 on Wednesday. The firm has a market capitalization of $48.69 million, a P/E ratio of -4.15 and a beta of 1.16. The business has a 50-day moving average of $1.41 and a 200-day moving average of $1.71. The company has a current ratio of 1.73, a quick ratio of 1.38 and a debt-to-equity ratio of 0.46. Rockwell Medical has a 1 year low of $1.16 and a 1 year high of $6.24.
Institutional Inflows and Outflows
About Rockwell Medical
Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.
Read More
- Five stocks we like better than Rockwell Medical
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Investing in Commodities: What Are They? How to Invest in Them
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.